Understanding Precision Oncology & Targeted Therapies for Cancer Patients

I ndia sees more than a million cases of cancer every year. While, countless efforts are being made all over the world to find a cure for this life-threating disease, we believe Precision Oncology can be the game changer in this direction.

Non-Invasive Natural Bypass Technique Can Treat Various Heart Conditions

A ttributing to increase in changing lifestyle, people of¬ten miss out on taking care of their health as a result of which there is an exponential increase of non-communicable diseases among the middle-aged population in the last decade.

Mehta Pharmaceuticals shuts its 100-yrs-old Chheharta unit

Over 100 workers at a Mehta Pharmaceuticals facility in Chheharta that produced active pharmaceutical ingredients (API) from natural extracts and was recently shutdown has lost their jobs. There is currently just one API manufacturing unit left in...

AstraZeneca's antibody cocktail backed for treating COVID in EU

AstraZeneca's antibody cocktail for preventing COVID-19, Evusheld, has now been recommended for treating the disease in the European Union , the company said on Friday, potentially broadening the market for a key therapy...

Mankind Pharma files Draft Red Herring Prospectus with SEBI

Mankind Pharma Limited has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI)...

How Pharmaceutical Industry can Generate Value from Digitalization

The pharmaceuticals industry & life sciences industry when compared to various other industries is usually advanced in their application of technology. But when it comes to operations, the pharma sector has been cautious in adopting new technologies.

Glenmark bets on respiratory drug, licensing deals to improve business

Glenmark Pharmaceuticals is banking on global rollout of specialty respiratory drug Ryaltris, making its US-based innovation unit Ichnos self-sustaining through more licensing deals, and expansion of branded formulation business in India, to help...

How New operating models are impacting pharma sector

Like many other industries in the pharmaceutical industry the pandemic suddenly made enterprises to operate differently. For example, all the in-person meetings became virtual.

Indian pharma industry likely to grow $130 bn by 2030

The Indian pharma industry is expected to grow to $130 billion by 2030 and become the leading provider of medicines to the world, said Indian Pharmaceutical Alliance (IPA) Secretary General...

Singapore grants interim approval for Moderna's bivalent COVID-19 booster vaccine

Singapore granted interim authorisation for a bivalent COVID-19 booster vaccine made by Moderna, the government said in a statement...

© 2025 India Pharma Outlook. All Rights Reserved.